In March 2019, the United States Food & Drug Administration approved ketamine for treatment-resistant depression. Ketamine-assisted therapy is the first approved psychedelic therapy and is beginning to become widely available and we hope to see FDA approval or Right to Try Access for MDMA and psilocybin in the near future. Today we wanted to share information about ketamine from our supporters at KAP Kansas City:
Ketamine Assisted Psychotherapy (KAP) has been used widely, particularly in the Bay Area of California, for several years. Practices have opened across the country as more licensed mental health providers and physicians become trained on the model. KAP Kansas City opened in 2020 as the area's first provider of ketamine assisted psychotherapy.
The KAP model uses dosing strategies to work with non-ordinary states of consciousness to address depression, anxiety, trauma, and self limiting thought and behavior patterns. KAP is a transpersonal and relational model, as the client is supported before, during and after the ketamine experience. The model trusts each person’s inner healing wisdom to gain insights and create an alignment with the self, apart from distress and difficulties.
Anne Bethune, LSCSW started KAP Kansas City in 2020 and was joined by Michael VanderWaal, LMSW in 2021. Both therapists have facilitated KAP sessions and have had their own experiences with ketamine assisted psychotherapy. We work with prescribing doctors to service KAP Kansas City clients for medical evaluation and prescription services. For more information visit www.kapkansascity.com.